Patents by Inventor Michael Jesson

Michael Jesson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating diabetes
    Publication number: 20070072830
    Abstract: The invention relates to compositions of Glu-boroPro and methods of use thereof in the prevention or management of type 2 diabetes.
    Type: Application
    Filed: September 15, 2006
    Publication date: March 29, 2007
    Applicant: Point Therapeutics, Inc.
    Inventors: Michael Jesson, Paul McLean, Glenn Miller, Barry Jones
  • Methods and compositions for treating glucose-associated conditions, metabolic syndrome, dyslipidemias and other conditions
    Publication number: 20060094693
    Abstract: The invention relates, in part, to of Glu-boroPro containing compounds and methods of use thereof in the prevention or management of conditions that are associated with impaired glucose tolerance such as diabetes. The invention also relates to compositions of Glu-boroPro containing compounds and methods of use thereof in the prevention or management of conditions such as metabolic syndrome, dyslipidemias, inflammation, cardiovascular disorders such as hypertension and atherosclerosis, and to reduce body weight or prevent weight gain. The compounds of the invention are also useful in lowering levels of triglycerides, free fatty acids, C-reactive protein (CRP), HbA1C, total glycosylated hemoglobin (TGHb), in increasing insulin sensitivity index and in stimulating insulin release.
    Type: Application
    Filed: September 21, 2005
    Publication date: May 4, 2006
    Applicant: Point Therapeutics, Inc.
    Inventors: Nazneen Aziz, Michael Jesson, Paul McLean, Glenn Miller, Barry Jones
  • Methods for treating diabetes
    Publication number: 20060063719
    Abstract: The invention relates to compositions of Glu-boroPro and methods of use thereof in the prevention or management of type 2 diabetes.
    Type: Application
    Filed: May 27, 2005
    Publication date: March 23, 2006
    Applicant: Point Therapeutics, Inc.
    Inventors: Michael Jesson, Paul McLean, Glenn Miller, Barry Jones
  • Boroproline compound combination therapy
    Publication number: 20050084490
    Abstract: A method is provided for treating subjects with combination therapy including compounds of Formula I. It was surprisingly discovered that this combination enhanced the efficacy of both agents, and that administration of Formula I compounds induced cytokine and chemokine production in vivo. The combinations can be used to enhance ADCC, stimulate immune responses and/or patient and treat certain disorders. The invention also relates to kits and compositions relating to such combinations.
    Type: Application
    Filed: July 9, 2003
    Publication date: April 21, 2005
    Applicant: Point Therapeutics, Inc.
    Inventors: Sharlene Adams, Glenn Miller, Michael Jesson, Barry Jones